Physician profile
Edred V Shen
NPI 1154302024
$327.36
in general payments reported to CMS, 2019-2025
9 companies · $65.29 in 2025
The $65.29 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $25.82 · 2021: $66.34 · 2022: $36.54 · 2023: $54.93 · 2024: $78.44 · 2025: $65.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $141 · Education: $32.27 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $141.39 |
| Education | $32.27 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $86.59 | 2020-2024 | |
| Exact Sciences Corporation | $59.89 | 2023-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $49.28 | 2021-2022 | |
| Novo Nordisk INC | $44.86 | 2022-2025 | |
| Becton, Dickinson and Company | $25.00 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.00 | 2024 | Trulance, Xifaxan |
| Lilly USA, LLC | $16.68 | 2024 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.25 | 2025 | Jardiance |
| Abbott Laboratories | $12.81 | 2023 | Freestyle Libre 2 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edred Shen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.